3 Days
|
mmu04510 |
Focal adhesion |
<0.001 |
19 |
199 |
mmu04512 |
ECM receptor interaction |
<0.001 |
11 |
88 |
mmu05200 |
Pathways in cancer |
0.003 |
21 |
539 |
2 Weeks
|
mmu04520 |
Adherens junction |
<0.001 |
27 |
71 |
mmu04510 |
Focal adhesion |
<0.001 |
44 |
199 |
mmu04270 |
Vascular smooth muscle contraction |
<0.001 |
29 |
140 |
mmu04360 |
Axon guidance |
<0.001 |
30 |
180 |
mmu04916 |
Melanogenesis |
<0.001 |
24 |
100 |
mmu05414 |
Dilated cardiomyopathy |
<0.001 |
23 |
94 |
mmu05200 |
Pathways in cancer |
<0.001 |
51 |
539 |
mmu04330 |
Notch signaling pathway |
<0.001 |
16 |
54 |
mmu04540 |
Gap junction |
<0.001 |
21 |
86 |
mmu04810 |
Regulation of actin cytoskeleton |
<0.001 |
36 |
216 |
mmu04740 |
Olfactory transduction |
<0.001 |
5 |
1134 |
mmu04912 |
GnRH signaling pathway |
<0.001 |
21 |
90 |
mmu04310 |
Wnt signaling pathway |
<0.001 |
26 |
162 |
mmu05217 |
Basal cell carcinoma |
<0.001 |
14 |
63 |
mmu04020 |
Calcium signaling pathway |
0.001 |
27 |
192 |
mmu05410 |
Hypertrophic cardiomyopathy (HCM) |
0.001 |
17 |
91 |
mmu04512 |
ECM receptor interaction |
0.002 |
16 |
88 |
mmu05412 |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) |
0.002 |
15 |
77 |
mmu05213 |
Endometrial cancer |
0.003 |
11 |
58 |
mmu04144 |
Endocytosis |
0.003 |
27 |
269 |
mmu11190 |
Dorso-ventral axis formation |
0.005 |
7 |
22 |
mmu05211 |
Renal cell carcinoma |
0.005 |
13 |
68 |
mmu05016 |
Huntingtons disease |
0.005 |
25 |
199 |
mmu04720 |
Long term potentiation |
0.006 |
13 |
67 |
mmu04260 |
Cardiac muscle contraction |
0.010 |
14 |
86 |
6 Weeks
|
mmu04142 |
Lysosome |
<0.001 |
23 |
124 |
3 Months
|
mmu04142 |
Lysosome |
<0.001 |
43 |
124 |
mmu04740 |
Olfactory transduction |
<0.001 |
4 |
1134 |
mmu04060 |
Cytokine-cytokine receptor interaction |
<0.001 |
60 |
296 |
mmu05140 |
Leishmania infection |
<0.001 |
27 |
69 |
mmu04062 |
Chemokine signaling pathway |
<0.001 |
45 |
198 |
mmu04650 |
Natural killer cell mediated cytotoxicity |
<0.001 |
34 |
117 |
mmu04612 |
Antigen processing and presentation |
<0.001 |
23 |
91 |
mmu05332 |
Graft versus host disease |
<0.001 |
15 |
65 |
mmu04662 |
B cell receptor signaling pathway |
<0.001 |
22 |
82 |
mmu04666 |
Fc gamma R-mediated phagocytosis |
<0.001 |
26 |
90 |
mmu04620 |
Toll like receptor signaling pathway |
<0.001 |
25 |
99 |
mmu05330 |
Allograft rejection |
<0.001 |
14 |
63 |
mmu16848 |
Epithelial cell signaling in helicobacter pylori infection |
<0.001 |
21 |
69 |
mmu04940 |
Type I diabetes mellitus |
<0.001 |
15 |
70 |
mmu04664 |
Fc epsilon RI signaling pathway |
0.001 |
20 |
67 |
mmu05320 |
Autoimmune thyroid disease |
0.002 |
14 |
78 |
mmu05416 |
Viral myocarditis |
0.006 |
17 |
88 |
mmu04660 |
T cell receptor signaling pathway |
0.006 |
23 |
103 |
mmu04640 |
Hematopoietic cell lineage |
0.008 |
18 |
95 |
mmu04672 |
Intestinal immune network for IgA production |
0.009 |
12 |
42 |